Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private equity firm J-Will Partners Co., Ltd. ("J-Will”), through which JKI will ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone. The ...

Pre-Market: 7:25:59 a.m. EST ...

HUNTSVILLE, Ala. (WAFF) - There is now an FDA-approved alternative to the EpiPen. A new nasal spray, called Neffy, can be used by people to treat severe allergic reactions. The new spray has already ...

THIS IS IT. THIS IS AN EPIPEN. AND THIS. THIS PROBABLY LIKELY COULD HAVE SAVED HER LIFE. YOU RECOGNIZE DOCTOR TODD ELLEN, VICE CHAIR OF MEDICINE AT SOUTH SHORE HEALTH. SO LET’S START THERE ...

After hours: 10 December at 18:59:52 GMT-5 ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 153,500 newsletter subscribers for 21 days.

Boehringer Ingelheim, GSK, Novartis, Teva, and Covis Pharma have been taken ... letters – aimed at manufacturers of asthma inhalers, epinephrine autoinjectors, and other drug products ...